3 documents found, page 1 of 1
Factors associated with disease flare following SARS-CoV-2 vaccination in peopl...
Farisogullari, Bayram; Lawson-Tovey, Saskia; Hyrich, Kimme L.; Gossec, Laure; Carmona, Loreto; Strangfeld, Anja; Mateus, Elsa F.; Schäfer, MartinFunding Information: Financial support from the European Alliance of Associations for Rheumatology (EULAR). Publisher Copyright: © European Alliance of Associations for Rheumatology, EULAR 2024. Re-use permitted under CC BY-NC-ND. No commercial re-use. No derivatives. See rights and permissions. Published by BMJ on behalf of EULAR.; Objectives: To investigate the frequency and factors associated with disease fl...
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and muscul...
Lawson-Tovey, Saskia; Machado, Pedro M.; Strangfeld, Anja; Mateus, Elsa; Gossec, Laure; Carmona, Loreto; Raffeiner, Bernd; Bulina, InitaPublisher Copyright: © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.; BACKGROUND: There is a lack of data on SARS-CoV-2 vaccination safety in children and young people (CYP) with rheumatic and musculoskeletal diseases (RMDs). Current vaccination guidance is based on data from adults with RMDs or CYP without RMDs. OBJEC...
Spectrum of lymphomas across different drug treatment groups in rheumatoid arth...
Mercer, Louise K.; Regierer, Anne C.; Mariette, Xavier; Dixon, William G.; Baecklund, Eva; Hellgren, Karin; Dreyer, Lene; Hetland, Merete LundFunding: Individual registries had entered into agreements with pharmaceutical companies (AbbVie, BMS, Hospira, MSD, Pfizer, Roche, UCB, Samsung and Eli Lilly). The pharmaceutical companies funding these registers were, however, not involved in the planning of the project, the statistical analyses, the interpretation of the results or the decision to publish.; BACKGROUND: Lymphomas comprise a heterogeneous grou...